KRRO Company Profile and Key Details

NASDAQ : KRRO

Korro Bio

$13.50

-1.06-7.28%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Korro Bio, Inc. (KRRO) stock declined over -7.28%, trading at $13.50 on NASDAQ, down from the previous close of $14.56. The stock opened at $14.11, fluctuating between $13.10 and $14.46 in the recent session.

Stock Snapshot

14.56

Prev. Close

134.37M

Market Cap

13.1

Day Low

-1.16

P/E Ratio

-11.67

EPS (TTM)

N/A

Cash Flow per Share

14.11

Open

9.95M

Number of Shares

14.46

Day High

61.17%

Free Float in %

N/A

Book Value

193.29K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 13, 2026	14.42	14.46	13.10	13.50	193.48K
Jul 10, 2026	14.31	14.67	13.37	14.56	233.78K
Jul 09, 2026	14.72	15.16	14.00	14.30	163.45K
Jul 08, 2026	14.29	15.20	14.10	14.72	199.09K
Jul 07, 2026	14.06	15.10	13.85	14.49	245.01K
Jul 06, 2026	13.93	15.55	13.81	14.06	463.57K
Jul 02, 2026	13.81	14.25	13.13	14.00	324.6K
Jul 01, 2026	13.13	13.78	12.79	13.65	181.27K
Jun 30, 2026	13.22	13.48	12.67	13.18	109.04K
Jun 29, 2026	12.65	13.40	12.31	13.20	166.09K
Jun 26, 2026	12.09	13.14	12.09	12.70	788.71K
Jun 25, 2026	13.56	13.61	11.97	12.17	240.5K
Jun 24, 2026	13.71	15.09	13.09	13.77	448.89K
Jun 23, 2026	13.52	14.49	13.52	13.71	479.61K
Jun 22, 2026	12.99	13.95	12.60	13.90	378.25K
Jun 18, 2026	11.38	13.29	11.23	12.99	734.26K
Jun 17, 2026	10.76	11.50	10.73	11.05	143.44K
Jun 16, 2026	11.65	11.69	10.55	10.66	221.5K
Jun 15, 2026	11.83	12.51	11.53	11.66	244.83K
Jun 12, 2026	10.53	13.07	10.50	11.61	315.44K

Contact Details

Cambridge, MA 02139-1562

United States

https://www.korrobio.com 781 315 4600

About Company

Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.

Stock Peers

ARGX

-1.37-0.16%

argenx SE$876.25 REGN

-1.43-0.22%

Regeneron Pharmaceuticals, Inc.$663.09 UTHR

-11.49-2.10%

United Therapeutics Corporation$535.57 MDGL

-5.7-1.06%

Madrigal Pharmaceuticals, Inc.$531.00 VRTX

-5.14-1.06%

Vertex Pharmaceuticals Incorporated$480.25 KRYS

-2.37-0.65%

Krystal Biotech, Inc.$363.44 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-10.43-3.21%

Praxis Precision Medicines, Inc.$314.56 LGND

-6.99-2.21%

Ligand Pharmaceuticals Incorporated$309.25 ONC

5.26001+1.76%

BeOne Medicines AG$303.96

Company Overview

Korro Bio, Inc. (NASDAQ:KRRO) closed at $13.50 USD, losing -$1.06 (-7.28%) from the previous close of $14.56. The stock is currently mid-range between its 52-week high and low $5.20 and $55.89. With a market capitalization of about $134.37 million, Korro Bio, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~2.11). Key stats such as the average daily volume over the past year has been around 177.38 thousand shares, in line with its 52-week average. Headquartered in Cambridge, MA, Korro Bio, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Ram Aiyar, the company employs approximately 49 people and listed since October 03, 2019. Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics.

Frequently Asked Questions

What is the current Korro Bio, Inc. (KRRO) stock price?

Korro Bio, Inc. (NASDAQ: KRRO) stock price is $13.50 in the last trading session. During the trading session, KRRO stock reached the peak price of $14.46 while $13.10 was the lowest point it dropped to. The percentage change in KRRO stock occurred in the recent session was -7.28% while the dollar amount for the price change in KRRO stock was - $1.06.

KRRO's industry and sector of operation?

The NASDAQ listed KRRO is part of Biotechnology industry that operates in the broader Healthcare sector. Korro Bio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of KRRO?

No Data

How KRRO did perform over past 52-week?

KRRO's closing price is 159.42% higher than its 52-week low of $5.20 where as its distance from 52-week high of $55.89 is -75.84%.

How many employees does KRRO have?

Number of KRRO employees currently stands at 49.

Link for KRRO official website?

Official Website of KRRO is: https://www.korrobio.com

How do I contact KRRO?

KRRO could be contacted at phone 781 315 4600 and can also be accessed through its website. KRRO operates from One Kendall Square, Cambridge, MA 02139-1562, United States.

How many shares of KRRO are traded daily?

KRRO stock volume for the day was 193.29K shares. The average number of KRRO shares traded daily for last 3 months was 177.39K.

What is the market cap of KRRO currently?

The market value of KRRO currently stands at $134.37M with its latest stock price at $13.50 and 9.95M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

Stock Snapshot

14.56

Prev. Close

134.37M

Market Cap

13.1

Day Low

-1.16

P/E Ratio

-11.67

EPS (TTM)

N/A

Cash Flow per Share

14.11

Open

9.95M

Number of Shares

14.46

Day High

61.17%

Free Float in %

N/A

Book Value

193.29K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 13, 2026	14.42	14.46	13.10	13.50	193.48K
Jul 10, 2026	14.31	14.67	13.37	14.56	233.78K
Jul 09, 2026	14.72	15.16	14.00	14.30	163.45K
Jul 08, 2026	14.29	15.20	14.10	14.72	199.09K
Jul 07, 2026	14.06	15.10	13.85	14.49	245.01K
Jul 06, 2026	13.93	15.55	13.81	14.06	463.57K
Jul 02, 2026	13.81	14.25	13.13	14.00	324.6K
Jul 01, 2026	13.13	13.78	12.79	13.65	181.27K
Jun 30, 2026	13.22	13.48	12.67	13.18	109.04K
Jun 29, 2026	12.65	13.40	12.31	13.20	166.09K
Jun 26, 2026	12.09	13.14	12.09	12.70	788.71K
Jun 25, 2026	13.56	13.61	11.97	12.17	240.5K
Jun 24, 2026	13.71	15.09	13.09	13.77	448.89K
Jun 23, 2026	13.52	14.49	13.52	13.71	479.61K
Jun 22, 2026	12.99	13.95	12.60	13.90	378.25K
Jun 18, 2026	11.38	13.29	11.23	12.99	734.26K
Jun 17, 2026	10.76	11.50	10.73	11.05	143.44K
Jun 16, 2026	11.65	11.69	10.55	10.66	221.5K
Jun 15, 2026	11.83	12.51	11.53	11.66	244.83K
Jun 12, 2026	10.53	13.07	10.50	11.61	315.44K

Contact Details

Cambridge, MA 02139-1562

United States

https://www.korrobio.com 781 315 4600

About Company

Stock Peers

ARGX

-1.37-0.16%

argenx SE$876.25 REGN

-1.43-0.22%

Regeneron Pharmaceuticals, Inc.$663.09 UTHR

-11.49-2.10%

United Therapeutics Corporation$535.57 MDGL

-5.7-1.06%

Madrigal Pharmaceuticals, Inc.$531.00 VRTX

-5.14-1.06%

Vertex Pharmaceuticals Incorporated$480.25 KRYS

-2.37-0.65%

Krystal Biotech, Inc.$363.44 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-10.43-3.21%

Praxis Precision Medicines, Inc.$314.56 LGND

-6.99-2.21%

Ligand Pharmaceuticals Incorporated$309.25 ONC

5.26001+1.76%

BeOne Medicines AG$303.96

Company Overview

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 0.08%, SMA50 19.31%, SMA200 -36.05%). The stock’s 14-day RSI is 56.18 (neutral), while the ATR of 0.98 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -78.35% below its high and over 132.5% above its low. Average 10-day trading volume of 249.73 thousand shares is slightly above the 3-month average of 182.51 thousand, indicating heightened recent market interest.

Valuation Metrics

Korro Bio, Inc. trades at a P/E ratio of -1.13, slightly below the S&P 500 average, with a price-to-sales ratio of 34.2 and a price-to-book ratio of 1.28 suggesting the stock is closer to book value. The P/FCF stands at -1.86, also above market averages.

Dividend & Fair Value

Korro Bio, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$5.42. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Korro Bio, Inc. generated EPS of -$9.42 over the past year. Five-year average earnings growth is 21.83%. Wall Street analysts project EPS growth of 6.31% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 6 Strong Buy ratings, 9 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $147.00 to $7.00. The high target offers 988.89% upside. The low target suggests -48.15% downside. The mean target is $39.82. This offers 194.96% upside. Korro Bio, Inc. earnings surprise history is a mixed track record. The quarter that ended May 07, 2026, missed forecasts by -2.12%. The prior quarter beat by 175.65%. Over the last six quarters, Apple has recorded several small beats. These include -3.0% in March 18, 2025.

Shareholding & Insider Activity

Korro Bio, Inc. has 9.39 million shares outstanding. The public float is 5.74 million shares, elevated short interest at 16.70% of float. This equals 1.19 million shares. The short ratio is 9.78 days. Institutional investors hold 103.72% of the float. Insiders own 6.18%. Lynx1 Capital Management LP holds 1.54 million shares, Yang Rick has 242.94 thousand shares and SANDELL SCOTT D has 242.94 thousand shares. Over the past six months, insider transactions show net selling. They sold 73.52 thousand shares across 11 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Korro Bio has not generated any revenue.
On valuation metrics, Korro Bio trades at a P/E of -1.13, P/S of 34.20 and P/B of 1.28. The current ratio is 8.13 and quick ratio is 8.13. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -694.17 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.36, supported by a cash flow-to-debt ratio of -1.64.

Price Forecast & Outlook

Our AI price prediction model suggests that Korro Bio, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 9.93%, with price expected at $14.84 by July 27, 2026, within a range of $13.29 to $16.26 3-Month Outlook: Projected rise of 299.19%, reaching $53.89 by October 08, 2026, with a range of $51.05 to $56.16. 1-Year Outlook: Projected loss of -94.44%, with price at $0.75 by July 13, 2027, within a range of $0.00 to $0.00.

Key Takeaways

Korro Bio, Inc. (NASDAQ:KRRO) shares are flat 7.12% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Korro Bio, Inc. trading at a premium to the broader market with a P/E of -1.13. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $59.50, suggesting 340.74% upside. Our AI forecast model points to short-term strength (9.93% over two weeks), a medium-term rise (299.19% over three months), and a longer-term loss (-94.44% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Korro Bio, Inc. (KRRO) stock price?

KRRO's industry and sector of operation?

Who are the executives of KRRO?

No Data

How KRRO did perform over past 52-week?

KRRO's closing price is 159.42% higher than its 52-week low of $5.20 where as its distance from 52-week high of $55.89 is -75.84%.

How many employees does KRRO have?

Number of KRRO employees currently stands at 49.

Link for KRRO official website?

Official Website of KRRO is: https://www.korrobio.com

How do I contact KRRO?

KRRO could be contacted at phone 781 315 4600 and can also be accessed through its website. KRRO operates from One Kendall Square, Cambridge, MA 02139-1562, United States.

How many shares of KRRO are traded daily?

KRRO stock volume for the day was 193.29K shares. The average number of KRRO shares traded daily for last 3 months was 177.39K.

What is the market cap of KRRO currently?

The market value of KRRO currently stands at $134.37M with its latest stock price at $13.50 and 9.95M of its shares outstanding.

Employees	49
Beta	2.11
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

KRRO Company Profile and Key Details

Korro Bio

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Dividend & Fair Value

Earnings & Analyst Outlook

Technical Performance

Valuation Metrics

Shareholding & Insider Activity

Price Forecast & Outlook

Key Takeaways

Financial & Profitability Overview